Mesenchymal chondrosarcoma in central nervous system: a clinicopathological analysis
10.3760/cma.j.cn112151-20210302-00176
- VernacularTitle:中枢神经系统间叶性软骨肉瘤临床病理学分析
- Author:
Qian HUANG
1
;
Yupeng CHEN
;
Fangling SONG
;
Limei ZHENG
;
Xueyong LIU
;
Sheng ZHANG
;
Xingfu WANG
Author Information
1. 福建医科大学附属第一医院病理科，福州350005
- Keywords:
Chondrosarcoma, mesenchymal;
Central nervous system neoplasms;
Diagnosis, differential;
NCOA2
- From:
Chinese Journal of Pathology
2021;50(8):870-875
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the clinicopathological features of central nervous system (CNS) mesenchymal chondrosarcoma (MCS).Methods:Nine cases of CNS MCS were collected at the First Affiliated Hospital of Fujian Medical University from September 2010 to September 2020. The clinical,imaging,histopathological and immunohistochemical features were reviewed. NCOA2 gene rearrangement was evaluated by fluorescence in situ hybridization (FISH).Results:There were three male and six female patients, with age range of 1 to 59 years (median 31 years). Six cases were intracranial and three cases were intraspinal, and the tumors showed dural attachment. They were often diagnosed as meningioma basing on preoperative imaging. Microscopically, the tumors showed a characteristic biphasic histologic pattern composed of undifferentiated mesenchymal small cells and well-differentiated hyaline cartilage islands. The small cells area were positive for SOX9 (9/9), CD99 (8/9), and without BRG1 and INI1 deletion. The cartilaginous component expressed SOX9 (9/9) and S-100 protein (8/9). NCOA2 gene break apart signal was identified in five cases (5/5). Eight patients were followed up for 4-124 months. Three patients (3/8) had recurrences within one year and two patients died of the tumor.Conclusions:CNS MCS is an extremely rare malignant neoplasm with a propensity to dural involvement. Preoperative imaging has low diagnostic accuracy. CNS MCS should be differentiated from other CNS small round cell tumors and chondrosarcoma. FISH detection of NCOA2 gene rearrangement will assist the diagnosis of MCS.
